Cargando…
Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events
Awareness of racial/ethnic disparities represents a key challenge for healthcare systems that attempt to provide effective healthcare and to reduce existing inequalities in the use of and adherence to guideline-recommended cardiovascular drugs to improve clinical outcomes for cardiovascular disease...
Autores principales: | Tamargo, Juan, Kaski, Juan Carlos, Kimura, Takeshi, Barton, Jack Charles, Yamamoto, Ko, Komiyama, Maki, Drexel, Heinz, Lewis, Basil S, Agewall, Stefan, Hasegawa, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520447/ https://www.ncbi.nlm.nih.gov/pubmed/35848895 http://dx.doi.org/10.1093/ehjcvp/pvac040 |
Ejemplares similares
-
Ethnic and Regional Differences in the Management of Angina: The Way Forward
por: Barton, Jack C, et al.
Publicado: (2022) -
Racial/ethnic disparities in early‐onset colorectal cancer: implications for a racial/ethnic‐specific screening strategy
por: Acuna‐Villaorduna, Ana R., et al.
Publicado: (2021) -
Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Komiyama, Maki, et al.
Publicado: (2020) -
Anticoagulant Therapy for Patients with Coronavirus Disease 2019: Urgent Need for Enhanced Awareness
por: Komiyama, Maki, et al.
Publicado: (2020) -
Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic
por: Komiyama, Maki, et al.
Publicado: (2020)